Naloxone Prescribing and Naloxone Administration in Response to Overdose Events Among Women With Opioid Use Disorder During Pregnancy and Postpartum Period – MAT-LINK, Seven Clinical Sites, 2014–2021
These findings highlight the need for further investigation into barriers and facilitators to naloxone clinical documentation, access, and use during the perinatal period.
Authors
- Neil S. Seligman (ORCID: https://orcid.org/0000-0003-1491-990X)
- Kathryn Miele (ORCID: https://orcid.org/0000-0003-4672-4728)
- Kaitlin Schrote (ORCID: https://orcid.org/0000-0003-2486-9993)
- Mei Elansary (ORCID: https://orcid.org/0000-0002-6695-6668)
- Pierre-Olivier Cote
- M. Terplan
- Marcela C. Smid
- Amy Board
- Anthony Kendle
- Shin Y. Kim
- Autumn Davidson
- Kara Rood
- Shawn A. Thomas
- Pilar M. Sanjuan
Publication Details
- Journal
- Journal of Addiction Medicine
- Published
- 2026-01-26
- DOI
- https://doi.org/10.1097/adm.0000000000001655
- Primary Topic
- Prenatal Substance Exposure Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00